Urgent Call to Investors: Join the Class Action for Applied Therapeutics, Inc. Losses
In a serious development for investors in Applied Therapeutics, Inc. (NASDAQ: APLT), the Gross Law Firm has issued a notice urging shareholders who experienced financial losses to consider joining a class action lawsuit. This comes in light of the company's recent challenges, particularly regarding its lead drug candidate, govorestat. On November 27, 2024, Applied Therapeutics made headlines after receiving a Complete Response Letter (CRL) from the FDA, indicating that the agency could not approve their New Drug Application (NDA) due to critical deficiencies in their clinical trials.
The implications of this announcement were immediately felt in the stock market. Following the news, APLT’s stock price plummeted significantly. It dropped from a closing price of $10.21 on November 26, 2024, to $8.57 the next day and tragically continued to decline to $2.03 by November 29, 2024, marking a staggering loss of over 80%. The situation worsened when, on December 2, 2024, the company disclosed that it had received a 'warning letter' from the FDA concerning these clinical trial issues. This news caused the stock price to dive further, hitting $1.75 per share, and continued to slide down to $1.29 by December 5, 2024.
As the financial consequences of these events weigh heavily on current and former shareholders, the Gross Law Firm encourages individuals who acquired APLT shares between January 3, 2024, and December 2, 2024, to take immediate action. Shareholders are reminded that they do not need to be appointed as a lead plaintiff to participate in any potential recovery from this class action. There is no cost associated with joining the lawsuit, making it a low-risk opportunity for those seeking compensation for their losses.
Interested shareholders can register through the Gross Law Firm’s dedicated portal. This registration not only allows participants to join the class action but also enrolls them in a portfolio monitoring service that will provide updates on the case as it progresses. The deadline for registering is February 18, 2025, so it is vital for affected shareholders to act swiftly.
The Gross Law Firm prides itself on advocating for investors’ rights, focusing on transparency and ethical corporate practices. They aim to support shareholders affected by alleged fraud, manipulation, or other unlawful conduct by companies. By joining this class action lawsuit, investors can potentially reclaim some of the financial losses incurred due to the recent developments at Applied Therapeutics.
For those interested in contacting the Gross Law Firm for more information or to register, their New York office can be reached at (646) 453-8903, and additional details can be found on their website. Protect your investments and explore your options today.
The implications of this announcement were immediately felt in the stock market. Following the news, APLT’s stock price plummeted significantly. It dropped from a closing price of $10.21 on November 26, 2024, to $8.57 the next day and tragically continued to decline to $2.03 by November 29, 2024, marking a staggering loss of over 80%. The situation worsened when, on December 2, 2024, the company disclosed that it had received a 'warning letter' from the FDA concerning these clinical trial issues. This news caused the stock price to dive further, hitting $1.75 per share, and continued to slide down to $1.29 by December 5, 2024.
As the financial consequences of these events weigh heavily on current and former shareholders, the Gross Law Firm encourages individuals who acquired APLT shares between January 3, 2024, and December 2, 2024, to take immediate action. Shareholders are reminded that they do not need to be appointed as a lead plaintiff to participate in any potential recovery from this class action. There is no cost associated with joining the lawsuit, making it a low-risk opportunity for those seeking compensation for their losses.
Interested shareholders can register through the Gross Law Firm’s dedicated portal. This registration not only allows participants to join the class action but also enrolls them in a portfolio monitoring service that will provide updates on the case as it progresses. The deadline for registering is February 18, 2025, so it is vital for affected shareholders to act swiftly.
The Gross Law Firm prides itself on advocating for investors’ rights, focusing on transparency and ethical corporate practices. They aim to support shareholders affected by alleged fraud, manipulation, or other unlawful conduct by companies. By joining this class action lawsuit, investors can potentially reclaim some of the financial losses incurred due to the recent developments at Applied Therapeutics.
For those interested in contacting the Gross Law Firm for more information or to register, their New York office can be reached at (646) 453-8903, and additional details can be found on their website. Protect your investments and explore your options today.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.